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Abstract. 
 
Laminins, the main components of basement 
membranes, are heterotrimers consisting of 
 
a
 
, 
 
b
 
, and 
 
g
 
 
polypeptide chains linked together by disulfide bonds. 
Laminins-1 and -2 are both composed of 
 
b
 
1 and 
 
g
 
1 
chains and differ from each other on their 
 
a
 
 chain, 
which is 
 
a
 
1 and 
 
a
 
2 for laminin-1 and -2, respectively. 
The present study shows that whereas laminins-1 and -2 
are synthesized in the mouse developing lung and in ep-
ithelial–mesenchymal cocultures derived from it, epi-
thelial and mesenchymal monocultures lose their abil-
ity to synthesize the laminin 
 
a
 
1 chain. Synthesis of 
laminin 
 
a
 
1 chain however returns upon re-establish-
ment of epithelial–mesenchymal contact. Cell–cell con-
tact is critical, since laminin 
 
a
 
1 chain is not detected in 
monocultures exposed to coculture-conditioned me-
dium or in epithelial–mesenchymal cocultures in which 
heterotypic cell–cell contact is prevented by an inter-
posing filter. Immunohistochemical studies on cocul-
tures treated with brefeldin A, an inhibitor of protein 
secretion, indicated both epithelial and mesenchymal 
cells synthesize laminin 
 
a
 
1 chain upon heterotypic cell–
cell contact. In a set of functional studies, embryonic 
lung explants were cultured in the presence of mono-
clonal antibodies to laminin 
 
a
 
1, 
 
a
 
2, and 
 
b
 
/
 
g
 
 chains. 
Lung explants exposed to monoclonal antibodies to 
laminin 
 
a
 
1 chain exhibited alterations in peribronchial 
cell shape and decreased smooth muscle development, 
as indicated by low levels of smooth muscle 
 
a
 
 actin and 
desmin. Taken together, our studies suggest that lami-
nin 
 
a
 
1 chain synthesis is regulated by epithelial–mesen-
chymal interaction and may play a role in airway 
smooth muscle development.
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1. 
 
Abbreviations used in this paper
 
: BM, basement membrane; LM, laminin.
 
B
 
asement
 
 membranes (BMs)
 
1
 
 are specialized, sheet-
like extracellular matrices that divide tissues into
compartments. The BMs function as a dynamic
structure in morphogenesis, cell differentiation, and main-
tenance of the mature cellular structural and functional
phenotypes (for review see Kleinman et al., 1993).
Laminins (LMs) are the major constituents of BMs. This
complex family of extracellular matrix proteins plays im-
portant roles in cell adhesion, growth, morphology, and
migration (Timpl and Brown, 1994). LMs consist of three
subunit polypeptide chains, classified as 
 
a
 
, 
 
b
 
, and 
 
g
 
 chains.
These are linked together by disulfide bonds and associate
into a cruciform tertiary structure by a triple-helical coiled
coil producing a long, rigid rod-like structure and two to
three shorter arms (for review see Engel, 1992). The dif-
ferent LM chains share partial homology, particularly in
the globular and rod-like domains containing EGF-like re-
peats (Engel, 1992) and domains participating in the
coiled-coil region (Iivanainen et al., 1995; Miner et al., 1995).
Additionally, the 
 
a
 
 chains contain a large COOH-terminal
globular domain with five internal repeat motifs that have
been identified as major sites for integrin binding (Hall et
al., 1990; Kramer et al., 1990; Elices et al., 1991) and hep-
arin binding (Skubitz et al., 1988).
The first LM reported, isolated from the Engelbreth
Holm-Shawm (EHS) tumor (Timpl, 1979), is now referred
to as LM-1(Burgeson et al., 1994) and is composed of 
 
a
 
1
(400 kD), 
 
b
 
1 (210 kD), and 
 
g
 
1 (200 kD) chains. LM-1 is
the earliest extracellular matrix molecule produced in
mouse embryogenesis (Wu et al., 1983), and during devel-
opment it can be detected in epithelial BMs of most or-
gans, including the lung (Wan et al., 1983; Klein et al.,
1990; Schuger et al., 1992). The presence of LM 
 
a
 
1, 
 
b
 
1,
and 
 
g
 
1 mRNA in the mouse lung epithelial and mesenchy-
mal compartments (Schuger et al., 1992; Thomas and To-
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ziadek, 1994; Lallemand et al., 1995) suggests that both
cell populations contribute to its production. However,
other studies have shown an exclusively epithelial cell origin
(Klein et al., 1990). LM-1 deposits exclusively in epithelial
BMs. Vascular BMs and the rest of the extracellular ma-
trix do not contain LM-1 (Klein et al., 1990; Schuger et al.,
1992; Thomas and Toziadek, 1994; Lallemand et al., 1995;
Virtanen et al., 1996).
LM-1 plays important roles in lung development, more
specifically in the processes of branching morphogenesis
(Schuger et al., 1990
 
a
 
, 1991), BM assembly (Schuger et al.,
1995, 1996), epithelial cell adhesion (Matter and Laurie,
1994; Schuger et al., 1995), and epithelial cell polarization
(Schuger et al., 1990
 
b
 
, 1995, 1996). In addition, our recent
studies showed that LM-1 polymerization at the epithe-
lial–mesenchymal interface is required for normal ar-
rangement and polarization of bronchial smooth muscle
cells (Schuger, L., P. Yurchenco, and Y. Yang, manuscript
submitted for publication).
More recently, other LMs have been identified in the
developing lung, including LM-2 (Virtanen et al., 1996).
However, their functional activity and possible role in
morphogenesis remain to be elucidated. LM-2, formerly
referred to as merosin (Engvall, 1994), is the main LM in
striated muscle and differs from LM-1 only in its 
 
a
 
 chain
(
 
a
 
2, 
 
b
 
1, 
 
g
 
1).
Mouse lung development begins on day nine of gesta-
tion (Ten Have-Opbroek, 1981; Theiler, 1989) and culmi-
nates in the neonatal period giving rise to a complex pat-
tern of branched airways and alveoli (Ten Have-Opbroek,
1981). Cytological markers indicative of smooth muscle
differentiation, such as smooth muscle 
 
a
 
 actin, desmin,
and myosin start to appear in mesenchymal cells surround-
ing the trachea and main bronchi by days 11 to 12, pro-
gressing in a proximal to distal fashion (Roman and Mc-
Donald, 1992; Yang, Y., and L. Schuger, unpublished
observations). LM-1 deposition in the developing lung, al-
though restricted to the epithelial–mesenchymal interface,
coincides with the areas of bronchial smooth muscle devel-
opment. Smooth muscle cells are not detected in the lung
vasculature until late development (Roman and McDonald,
1992; Yang, Y., and L. Schuger, unpublished observations).
Here we present evidence suggesting that epithelial–
mesenchymal interaction is required for the synthesis of
the LM 
 
a
 
1 chain, while the LM 
 
a
 
2 chain is constitutively
synthesized by both cell types. Furthermore, monoclonal
antibodies to LM 
 
a
 
1 chain but not to LM 
 
a
 
2 or 
 
b
 
/
 
g
 
 chains
altered peribronchial mesenchymal cell shape and inhib-
ited smooth muscle development in lung organ cultures.
These results suggest that the LM 
 
a
 
1 chain synthesis is
stimulated by epithelial–mesenchymal contact and may
play a role in airway smooth muscle development.
 
Materials and Methods
 
Antibodies
 
A polyclonal antibody against murine EHS LM was generated as previ-
ously described (Palm and Furcht, 1983). The antibody reacts with LM-1
but not fibronectin or type IV collagen (McCarthy et al., 1983). The anti-
body was further purified on an LM-1 affinity column (McCarthy and
Furcht, 1984). Monoclonal antibodies to LM 
 
a
 
1 (referred to as AL-4) and
 
b
 
1/
 
g
 
1 chains (referred to as AL-3) were generated by the immunization of
male LOU/MNCr rats against murine EHS LM. The preparation, purifi-
cation, and characterization of these antibodies has been previously de-
scribed (Skubitz et al., 1987, 1988). Normal rat IgG was purchased from
Cappel (Malvern, PA). A monoclonal antibody to the LM 
 
a
 
2 chain (4H8-2)
was generated, purified, and characterized as previously described (Schuler
and Sorokin, 1995). This antibody does not recognize other LM chains
(Schuler and Sorokin, 1995). A rabbit polyclonal antibody to low and high
molecular weight cytokeratins was purchased from Dako (Carpinteria,
CA). A mouse monoclonal antibody to smooth muscle 
 
a
 
 actin was ob-
tained from Boehringer Mannheim (Indianapolis, IN). This antibody has
been shown to immunoreact with mouse smooth muscle 
 
a
 
 actin (Roman
and McDonald, 1992). A mouse monoclonal antibody to desmin was pur-
chased from Dako. EHS LM was purchased from Collaborative Biomedical
(Boston, MA).
 
Generation of Epithelial and Mesenchymal 
Monocultures and Cocultures
 
CD-1 strain (Charles River) mice were mated, and the day of finding a
vaginal plug was designated as day zero of embryonic development. Lungs
were removed at day 15 of gestation, minced, and placed in PBS contain-
ing 0.3% trypsin and 0.1% EDTA for 10 min at 37
 
8
 
C. A single cell suspen-
sion was obtained by forcing cell aggregates and pieces of tissue through a
micropipet several times. The cells were then filtered through a 100-
 
m
 
m-pore
mesh and resuspended in minimal essential medium (MEM; GIBCO BRL,
Gaithersburg, MD) with nonessential amino acids (GIBCO BRL), 0.29
mg/ml 
 
l
 
-glutamine, 100 U/ml penicillin, 100 
 
m
 
g/ml streptomycin, 0.25 mg/ml
amphotericin B, and 10% fetal bovine serum (Irvine Scientific, Santa
Ana, CA). Monocultures were generated by differential plating as previ-
ously described (Schuger et al., 1993). Culture samples were immuno-
stained with an anti-keratin antibody to identify epithelial cells. Only mes-
enchymal monocultures with 
 
,
 
1% keratin-positive cells and epithelial
monocultures with 10% or less mesenchymal cell contamination were
used to carry out experiments. Homotypic and heterotypic cocultures
were generated by plating mixed lung cell populations directly isolated
from fetal lungs, by plating together different numbers of epithelial and/or
mesenchymal cells obtained from monocultures, or by adding different
numbers of one cell type to an established monoculture of the same or the
other cell type.
The cultures were established in 24-well plates (GIBCO BRL) or on
the upper surface of polycarbonate membrane inserts (Millipore, Bed-
ford, MA). The polycarbonate membrane does not support cell attach-
ment, and under these conditions the cells cluster together at the center of
the insert, allowing maximal cell–cell interaction. Approximately 3 to 6 
 
3
 
10
 
5
 
 cells were added to each well or insert. The cells were cultured in com-
plete medium for 2 to 72 h. In some experiments involving epithelial–mes-
enchymal cocultures, the two cell populations were separated again by dif-
ferential plating at the end of the coculture period. All of the cultures
employed for these studies were at passages 0 to 2.
 
Treatment of Epithelial–Mesenchymal Cocultures
with Brefeldin A
 
In these studies, organotypic epithelial–mesenchymal cocultures were ex-
posed to the fungal metabolite brefeldin A (Sigma Chemical Co., St.
Louis, MO), an inhibitor of protein secretion at the pre-Golgi compart-
ment (Klausner et al., 1992), to determine what cell type synthesizes LM
 
a
 
1 chain. Organotypic cocultures were generated by plating mixed lung
cell populations isolated from fetal lungs at high densities (1–5 
 
3
 
 10
 
6
 
 cells/
ml; Schuger et al., 1993). When plated at high density, the lung epithelial
cells form spheroid clusters and cysts and the mesenchymal cells grow
around them as a monolayer (Schuger et al., 1993, 1995). 2-d-old organo-
typic cocultures were washed and incubated for 3 h in complete medium
supplemented with 0, 1, 5, and 10 
 
m
 
g/ml of brefeldin A. At the end of the
culture period the cultures were washed and immunostained as described
below.
 
Functional Studies on Lung Organ Cultures
 
Embryos were collected at day 12 of gestation. Their lungs were then dis-
sected and the lower right lobes were cultured at the air–medium interface
on the upper surface of polycarbonate membrane inserts, in a serum free-
defined medium, BGJb (GIBCO BRL; Schuger et al., 1996). The lung ex-
plants were cultured for 3 d in the presence of monoclonal antibodies to
LM 
 
a
 
1 chain (monoclonal antibody AL-4), 
 
a
 
2 chain (monoclonal anti- 
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body 4H8-2), LM 
 
b
 
1/
 
g
 
1 chain (monoclonal antibody AL-3), control IgG,
or no treatment. Previous studies demonstrated that these antibodies pen-
etrate into the lung explant and bind to the epithelial BM (Schuger et al.,
1991). The immunoglobulins were added to the organ cultures at concen-
trations of 10, 50, and 100 
 
m
 
g/ml at the beginning of the experiment. These
concentrations were not toxic to the cells as indicated by a cytotoxicity as-
say based on Cr
 
51
 
 release (Schuger et al., 1989; data not shown). Since the
embryonic lungs are transparent, the number of terminal airway buds was
daily determined as an indicator of branching morphogenesis. After 3 d in
culture, the explants were lysed or formalin fixed, and paraffin embedded.
5-
 
m
 
m-thick sections were cut from the latter and stained with hematoxy-
lin-eosin for light microscopy evaluation. These experiments were done in
triplicate wells (1 explant/well) and were repeated seven times.
 
Metabolic Labeling, Immunoprecipitation,
and SDS-PAGE
 
Epithelial and mesenchymal monocultures and cocultures (
 
z
 
2 
 
3
 
 10
 
7
 
 cells
each) were incubated for 30 min in methionine-free medium supple-
mented with 1 mCi/ml of [
 
35
 
S]methionine (NEN Dupont, Boston, MA).
After incubation, the cells were washed, cultured in cold medium for an
additional 30 min, and then lysed in SDS sample buffer (0.0625 M Tris-
HCL, pH 6.8, 10% glycerol, 2% SDS, and 2.5% 2 
 
b
 
-mercaptoethanol; all
from BioRad, Richmond, CA). LM-1 was precipitated from the lysates
with 10 
 
m
 
g/ml of monoclonal antibody AL-4 (against LM 
 
a
 
1 chain) and
protein A-Sepharose (Sigma Chemical Co.) as previously described
(Schuger et al., 1992). The immunoprecipitates were eluted and fraction-
ated in 4% polyacrylamide gels under reducing conditions. Radioactive
bands were visualized by exposing the dried gels to X-ray film (Kodak
XAR-2; Eastman Kodak Co., Rochester, NY).
 
Western Blotting
 
Cell monocultures, cocultures, and lung organ cultures were lysed by boil-
ing for 10 min in SDS sample buffer under reducing conditions for LM
and under nonreducing conditions for smooth muscle 
 
a
 
-actin and desmin.
Cell supernatants were diluted 1:2 in 2
 
3
 
 SDS sample buffer and boiled
under reducing conditions. 30 
 
m
 
g of sample was resolved in a 4% acryla-
mide gel for LM studies and in a 15% gel for smooth muscle 
 
a
 
 actin and
desmin studies. The samples were transferred to nitrocellulose mem-
branes (BioRad) according to the method of Towbin et al. (1979) and
blocked with 5% dry nonfat milk in TBS-T (20 mM Tris base, 137 mM so-
dium chloride, 0.05% Tween-20, pH 7.6; all from BioRad). The mem-
branes were then blotted for 1 h with a 1:100 dilution of polyclonal anti-
bodies to EHS LM that recognize LM 
 
a
 
1 and 
 
a
 
2 chains or monoclonal
antibodies to LM 
 
a
 
1 chain (AL-4), LM 
 
a
 
2 chain (4H8-2), smooth muscle
 
a
 
 actin, and desmin. This was followed by another hour of incubation with
a 1:3,000 dilution of the secondary antibody, goat anti–rat, anti–rabbit, or
anti–mouse IgG depending on the primary antibody. The bands were de-
tected by chemiluminescence using a commercial kit (Amersham Life Sci-
ence, Arlington Heights, IL) and following the manufacturer’s instruc-
tions.
 
Immunohistochemistry
 
Immunolocalization of LM 
 
a
 
1 chain was examined on organotypic cocul-
tures and on embryonic lungs. Occasionally, double immunostaining (im-
mufluorescence followed by immunoperoxidase) was done for LM-1 and
cytokeratins combined. Cocultures and 5-
 
m
 
m-thick lung frozen sections
were fixed for 5 min in absolute alcohol, exposed to 5% normal goat se-
rum followed by treatment with a 1:50 dilution of monoclonal antibody to
LM 
 
a
 
1 chain (AL-4) for 45 min at room temperature. The sections were
then washed in PBS and exposed to a 1:50 dilution of the secondary anti-
body (FITC-conjugated goat anti–rat IgG for LM-1; Cappel) for 30 min at
room temperature. To identify epithelial cells, some of the LM-1–stained
cocultures were then immunostained with anti-cytokeratin antibodies us-
ing a commercial peroxidase–anti-peroxidase kit (Dako) and following
the manufacturer’s instructions.
 
ELISA
 
Epithelial–mesenchymal cocultures and monocultures were washed and
incubated for 3 h in serum-free MEM containing 0.02% BSA (MEM-
BSA). The culture fluids were then collected and added to quadruplicate
wells of a 96-well plate (Falcon Plastics, Oxnard, CA) in aliquots of 0.1 ml/
 
well. MEM-BSA served as a negative control. Serial dilutions of LM-1
were added to the assay plates to serve as a positive standard. After a 4-h
incubation, the fluids were removed and the ELISA was performed as de-
scribed (Varani et al., 1985) using a monoclonal antibody to the LM 
 
a
 
1
chain (AL-4).
 
Results
 
LM-1 and LM-2 Are Expressed by the Mouse
Fetal Lung
 
Immunoblots using a polyclonal antibody against EHS
LM (Fig. 1, 
 
x-LM
 
) that recognizes both 
 
a
 
1 and 
 
a
 
2 chains,
a monoclonal antibody to LM 
 
a
 
1 chain (Fig. 1, 
 
x-LM 
 
a
 
1
 
),
and a monoclonal antibody to LM 
 
a
 
2 chain (Fig. 1, 
 
x-LM
 
a
 
2
 
) demonstrated the presence of LM 
 
a
 
1, 
 
a
 
2, 
 
b
 
1, and 
 
g1
chains in the mouse developing lung. We noticed that b1
and g1 chains frequently migrated with similar Mr produc-
ing a single band in minigels. However, the two bands
were resolved in larger gels.
LM a1 Chain is Induced by
Epithelial–Mesenchymal Interaction
Monocultures of lung epithelial and mesenchymal cells as
well as homotypic cocultures (epithelial cells added to an
established epithelial monoculture, E/E; or mesenchymal
cells added to an established mesenchymal monoculture,
M/M) synthesized LM a2, b1, and g1 but not a1 chain
(Fig. 2). Epithelial–mesenchymal cocultures synthesized
LM  a1 chain in addition to LM a2, b1, and g1 chains (Fig.
2). There were, however, differences in the amount of LM
a1 chain synthesized by the various heterotypic coculture
systems. Epithelial–mesenchymal cocultures established
by plating epithelial and mesenchymal cell populations di-
rectly after trypsinization of lungs (passage 0) synthesized
the highest levels of LM a1 chain (Fig. 3, column 1), whereas
cocultures established by adding one cell type on top of a
heterotypic cell monolayer synthesized the lowest levels
(Fig. 3, columns 3 and 4). Cocultures generated by plating
Figure 1. Immunoblots demonstrating the presence of LM a1,
a2, b1, and g1 chains in the developing lung (day 15 of gestation).
A polyclonal antibody against EHS LM that recognizes a1, a2,
b1, and g1 chains (x-LM), a monoclonal antibody to the LM a1
chain (AL-4, x-LM a1), and a monoclonal antibody to LM a2
chain (4H8-2, x-LM a2) were used in these studies. LM-1 from
the EHS tumor and embryonic heart (rich in LM-2) served as
controls. Immunoblots with normal rabbit IgG or rat IgG did not
detect any protein bands.The Journal of Cell Biology, Volume 139, 1997 556
a combination of epithelial and mesenchymal cells ob-
tained from monocultures at a ratio of 1:3 to 1:5 synthe-
sized intermediate levels of LM a1 chain (Fig. 3, column
2). In addition, these studies indicated that these cells may
require at least 4 h of coculture for LM a1 chain to be syn-
thesized, since LM a1 chains were not detected after 2 to 4 h
of coculture by ELISA (not shown).
Immunohistochemical studies showed that LM a1 chain
was deposited exclusively at the epithelial–mesenchymal
interface (Fig. 4). No significant amount of LM a1 chain
was detected intracellularly in either cell type. The re-
stricted epithelial–mesenchymal localization of LM a1 chain
was also observed in the developing lung. In day 12 lung,
LM-1 was found in the BM along the bronchial tree (Fig.
4,  inset) where more sustained epithelial–mesenchymal
contact occurred, but not at the tips of the growing bron-
chi, where new epithelial–mesenchymal contacts are con-
tinuously established.
Immunoprecipitation with a monoclonal antibody to the
LM a1 chain after metabolic radiolabeling confirmed the
synthesis of LM a1 chain by epithelial–mesenchymal co-
cultures but not by monocultures (Fig. 5). These studies
also showed that LM a1 chain is linked to b1 and g1 chains
forming full LM-1 molecules (Fig. 5).
Epithelial–mesenchymal cocultures separated by a filter
did not synthesize LM a1 chain, however a2, b1, and g1
expression remained constant (Fig. 6). No Lma1 chain was
produced by culturing monolayers in epithelial-, mesen-
chymal-, or epithelial–mesenchymal-conditioned medium
(not shown).
LM a1 chain synthesis seems to be directly proportional
to the extent of epithelial–mesenchymal contact. This was
suggested by studies in which increasing numbers of mes-
enchymal cells were added to prestablished (24-h-old) epi-
Figure 2. LM a1, a2, b1, and g1 chains produced by epithelial–
epithelial (E/E), mesenchymal–mesenchymal (M/M), and epithe-
lial–mesenchymal (E/M) cocultures. A polyclonal antibody
against EHS LM that recognizes a1, a2, b1, and g1 chains was
used for immunobloting. LM a1 chain is observed only in epithe-
lial–mesenchymal cocultures. As controls, the first lane contained
LM-1 from the EHS tumor and the second lane contained lung
extract. Immunoblots with normal rabbit IgG or rat IgG did not
detect any protein bands.
Figure 3. ELISA showing different levels of LM a1 chain synthe-
sis in different cocultures. (Column 1) Epithelial–mesenchymal
coculture established from mixed cell populations directly iso-
lated from the lung. (Column 2) Epithelial–mesenchymal cocul-
ture established with cells from monocultures mixed in a 1:3 epi-
thelial/mesenchymal ratio. (Column 3) Epithelial–mesenchymal
coculture established by adding epithelial cells to a mesenchymal
monolayer (both confluent at the time of determining LM-1 pro-
duction). (Column 4) Epithelial–mesenchymal coculture estab-
lished by adding mesenchymal cells to an epithelial monolayer
(both confluent at the time of determining LM-1 production).
The bars represent SD. The means and SD are based on quadru-
plicate examples in a single experiment. These were repeated
three times with similar results.
Figure 4. Epithelial–mesenchymal organotypic coculture double-
stained with anti-keratin antibodies by immunoperoxidase (a)
and with anti-LM a1 chain antibody by immunofluorescence (b).
The epithelial cells are recognized because they form round clus-
ters and stain light brown with anti-keratin antibodies (not clearly
appreciated in a black and white photograph). LM-1 is exclu-
sively deposited at the epithelial–mesenchymal interface (ar-
rows). (Inset) Day 12 lung stained with anti-LM a1 chain anti-
body shows LM-1 deposition restricted to the basement membrane
alongside the bronchial tree. Bar: (a and b) 20 mm; (inset) 0.2 mm.Schuger et al. Laminin a1 Synthesis Is Involved in Smooth Muscle Development 557
thelial monocultures (Fig. 7). These ratios were selected
based on the normal epithelial/mesenchymal ratio in mixed
lung cell populations obtained from day 15 embryonic
lungs.
LM  a1 Chain Is Synthesized by Epithelial and 
Mesenchymal Cells
Immunohistochemical studies showed no intracellular LM
a1 chain in epithelial–mesenchymal cocultures (Fig. 4).
Additionally, we could not determine by immunoblotting
or immunoprecipitation which cell population synthesized
LM a1 chain, because this chain disappeared very rapidly
after interruption of epithelial–mesenchymal contact. How-
ever, we occasionally noticed a faint band corresponding
to LM a1 chain in both epithelial and mesenchymal cell ly-
sates right after isolation from the lung or from hetero-
typic cocultures (not shown). To identify the origin of LM
a1 chain, we exposed organotypic cocultures to brefeldin
A, a fungal metabolite that inhibits protein secretion
(Klausner et al., 1992). In organotypic cocultures, the epi-
thelial cells form cysts and the mesenchymal cells sur-
round them as a monolayer (Schuger et al., 1993, 1995);
therefore, it is possible to determine what cell type accu-
mulates LM a1 chain. Immunolocalization studies in brefel-
din A-treated cultures indicated that LM a1 chain accu-
mulates in both the epithelial cells and in the mesenchymal
cells surrounding them (Fig. 8).
Functional Studies Showed Alterations in
Peribronchial Cell Shape in Lung Explants Exposed
to Anti-LM a1 Antibody
Day 12 lung explants were cultured for 3 d in the presence
of monoclonal antibodies to LM chains a1, a2, and b1/g1,
normal mouse IgG, or no immunoglobulin. Since embry-
onic lungs are transparent, the airway branching activity
was daily monitored by counting the number of terminal
airway buds per explant and looking for changes in airway
tree architecture or lumen caliber. All of the explants pre-
sented a similar number of terminal buds regardless of
treatment (32 6 8) and showed no changes in airway ar-
chitecture (not shown).
Microscopic evaluation of hematoxylin- and eosin-stained
sections showed well preserved epithelial and mesenchy-
mal cellular architecture with scattered mitotic figures in
both tissue compartments. A normal histological pattern
was seen in the mesenchyme of lung explants exposed to
antibodies against LM a2 or LM b1/g1 chains or to normal
mouse IgG. In these explants the peribronchial mesenchy-
mal cells were elongated in shape (polarized) and arranged
concentrically to the airway (Fig. 9, a, d, and e), whereas
the rest of the mesenchymal cells were round in shape (un-
polarized). However, in the lung explants exposed to 50 or
100 mg/ml of monoclonal antibody to LM a1 chain, the
mesenchymal cells were uniformly round (unpolarized),
regardless of their proximity to the bronchial tree (Fig. 9
b). The effect that mAb AL-4 had on mesenchymal cell
Figure 5. Immunoprecipitation of 35S-metabolically labeled LM-1
synthesized by epithelial (E) and mesenchymal (M) monocul-
tures and epithelial–mesenchymal cocultures (E/M) using a mono-
clonal antibody to the LM a1 chain. Only epithelial–mesenchy-
mal cocultures produced detectable levels of LM-1.
Figure 6. Immunoblots using a polyclonal antibody to LM-1 that
recognizes a1, a2, b1, and g1 chains. No LM a1 chain was de-
tected in epithelial–epithelial (E/E) or mesenchymal–mesenchy-
mal (M/M) cocultures, whereas LM a1 chain was seen in epithe-
lial–mesenchymal (E/M) cocultures. LM a1 chain was not
detected in the absence of epithelial–mesenchymal contact (mono-
cultures separated by a filter), whereas a2, b1, and g1 chains re-
mained constant. The first lane is LM-1 from the EHS tumor,
used as control.
Figure 7. Addition of mesenchymal cells to epithelial monocul-
tures stimulates LM a1 chain synthesis. (M2) No mesenchymal
cells; (M1) 1:2 epithelial/mesenchymal cell ratio; (M11) 1:4 epi-
thelial/mesenchymal cell ratio. The first lane is LM-1 from the
EHS tumor, used as control. The inset shows staining of the ni-
trocellulose membrane with 0.2% amido black after immunoblot-
ing to visualize the amount of protein loaded per lane.The Journal of Cell Biology, Volume 139, 1997 558
morphology was corrected by preincubation of AL-4 with
LM-1 (Fig. 9 c).
To assess the magnitude of this effect, longitudinal sec-
tions of each explant including the primary and secondary
bronchi were projected on a television screen, and the
number of mesenchymal cells with elongated (polarized)
nuclei and with round (unpolarized) nuclei was deter-
mined. Although the main bronchi were surrounded by
two to three concentric layers of elongated mesenchymal
cells, only the cells directly apposed to the BM were counted.
By using this semi-quantitative method, we found a sta-
tistically significant difference in the number of elongated
versus round peribronchial cells in the explants exposed to
50 or 100 mg/ml of anti-LM a1 chain antibody compared to
the other mAbs (Fig. 10). Notice the high percentage of
unpolarized peribronchial mesenchymal cells in the lung
explants exposed to anti-LM a1 chain antibody (P , 0.005,
with Student’s t test) and how this is corrected with prein-
cubation of the antibody with LM-1. No significant differ-
ences were found in the total number of mesenchymal
cells among the explants, including those treated with anti-
LM a1 chain (350 6 45).
Figure 8. Epithelial–mesen-
chymal organotypic cocul-
tures exposed to 0 (a), 5 (b),
and 10 (c) mg/ml of brefeldin
A for 3 h, followed by immu-
nostaining with anti-LM a1
chain antibody. e, Epithelial
cell;  m, mesenchymal cells. In
untreated cocultures (a), LM
a1 chain accumulates at the
epithelial–mesenchymal in-
terface (arrow). In brefeldin
A-treated cocultures (b and
c), LM a1 chain can be de-
tected in the epithelial cells
as well as in the mesenchy-
mal cells surrounding them
(b,  arrows). Bar, 20 mm.
Figure 9. Photomicrographs
of a main bronchus including
peribronchial mesenchymal
cells in lung explants cul-
tured for 3 d in the presence
of 100 mg/ml of normal
mouse IgG (a), anti-LM a1
chain antibody (b), anti-LM
a1 chain antibody preincu-
bated with 200 mg/ml of LM-1
(c), anti-LM a2 antibody
(d), and anti-LM b1/g1 anti-
body (e). Note that in the
control (a) the peribronchial
mesenchymal cells (m) are
polarized (elongated and ori-
ented concentrically to the
bronchus), whereas the peri-
bronchial mesenchymal cells
in explants exposed to anti-
LM a1 chain antibody (b)
are round. This effect was
corrected by preincubation
of the antibody with LM-1
(c) and was not observed in
explants exposed to the other
antibodies (d and e). The epi-
thelial cells (e) showed no
morphological alterations. Bar,
20 mm.
Figure 10. Histogram showing the percentage of polarized (elon-
gated) and unpolarized (round) peribronchial cells in day 12 em-
bryonic lung explants exposed for 3 d to various anti-LM anti-
bodies and control immunoglobulin. The number of polarized
(elongated) and unpolarized (round) peribronchial mesenchymal
cells was determined on histological sections of the explants.
These were cut longitudinally to and including the full main bron-
chus. Only the cells closest to the BM of the main bronchus and
its first order branches were quantitated. The bars represent SD.
The means and SD are based on five examples of each treatment.Schuger et al. Laminin a1 Synthesis Is Involved in Smooth Muscle Development 559
Functional Studies Suggested That LM a1 May Play a 
Role in Bronchial Smooth Muscle Development
To study the development of bronchial smooth muscle, we
used antibodies against two different smooth muscle-spe-
cific proteins, smooth muscle a actin and desmin. Desmin
is an intermediate filament expressed in all muscle tissue
and, when absent, results in smooth muscle hypoplasia and
degeneration (Milner et al., 1996). These antibodies recog-
nized the two proteins in immunoblots of mouse adult gut
(rich in smooth muscle) and fetal lung tissue lysates (Fig.
11). Lung explant cultured for 3 d in the presence of a
monoclonal antibody against LM a1 chain showed a de-
crease in smooth muscle a actin and desmin proportional
to the concentration of antibody (Fig. 12 a). No change in
smooth muscle a actin and desmin expression was ob-
served in lung explants cultured for 3 d in the presence of
monoclonal antibodies to LM a2 chain or to LM b1/g1
chains compared with controls (Fig. 12 b).
Discussion
Epithelial–Mesenchymal Contact Induces Synthesis of 
LM a1 Chain
Heterotypic cell interactions are long known to be essen-
tial for morphogenesis and cell differentiation, however,
the molecular mechanisms underlying these processes are
poorly understood. Most developing organs, including the
lung, are composed of two main cell populations, the epi-
thelium and the mesenchyme, separated by a BM. Among
the BM constituents, LM-1 is known to play a significant
role in morphogenic epithelial–mesenchymal interactions
(for review see Ekblom, 1996). In this study, using a com-
bination of monocultures and cocultures isolated from
mouse embryonic lungs, we show that epithelial–mesen-
chymal interaction induces the synthesis of the LM a1
chain.
LM a1 chain is not the first extracellular matrix protein
found to be modulated by epithelial–mesenchymal inter-
actions. In a previous study using tissue recombinants,
Vanio et al. (1989) showed that heterotypic interaction be-
tween epithelium and mesenchyme stimulates the synthe-
sis of syndecan and tenascin during mouse tooth develop-
ment. A similar mechanism seems to regulate the expression
of certain cytokines in the skin (Reusch et al., 1991; Smola
et al., 1993) and in the developing tooth (Mitsiadis et al., 1995).
Homotypic cocultures, epithelial–mesenchymal cocultures
separated by a filter, or monocultures exposed to condi-
tioned media, did not produce LM a1 chain, indicating
that LM a1 chain synthesis requires heterotypic cell–cell
contact. This kind of close cell–cell interaction does not
normally occur in the adult but is characteristic of devel-
oping organs. In the lung, epithelial and mesenchymal
cells are in direct contact at the ends of the bronchial tree,
where new airway buds are being formed (Grant et al., 1983;
Jaskoll and Slavkin, 1984). Deposition of LM a1 chain be-
gins at these sites, where it is barely detected, and gradu-
ally accumulates alongside the bronchial tree, where more
prolonged heterotypic cell–cell contact has time to occur.
The need for cellular contact was noticed in a variety of
cell–cell interactions (Reichmann et al., 1989; Reusch et
al., 1991; Yaeger, et al., 1991; Flaumenhaft et al., 1993;
Smola et al., 1993) and underscores the importance of jux-
tacrine or short range paracrine signals. Such mechanisms
have been proposed or demonstrated in many heterotypic
cell–cell interactions, including the activation of TGF-b in
smooth muscle cell–fibroblast coculture (Flaumenhaft et
al., 1993), the transactivation of TGF-a precursor by adja-
cent cells (Anklesaria et al., 1990), and the production of
casein by mammary epithelial cells upon coculture with
mammary mesenchymal cells (Reichmann et al., 1989).
Figure 11. Immunoblots us-
ing monoclonal antibodies
to smooth muscle a actin and
desmin on mouse adult gut
(rich in smooth muscle) and
fetal lung tissue lysates, the
latter on day 15 of gestation.
A single band migrating at an
Mr of z42,000, consistent
with smooth muscle a actin,
and a single band migrating
at an Mr of z52,000, consis-
tent with desmin, are visual-
ized in both adult gut and fe-
tal lung.
Figure 12. Detection of smooth muscle a actin (SM-actin) and
desmin in lung explants cultured for 3 d in the presence of mono-
clonal antibodies against LM chains or control IgG. There is a de-
crease in smooth muscle a actin and desmin proportional to the
concentration of anti-a1 chain antibody added to the lung organ
cultures (a). The inset shows a portion of the nitrocellulose mem-
brane stained with 0.2% amido black after immunobloting to vi-
sualize the amount of protein loaded per lane. No change in
smooth muscle a actin or desmin synthesis is observed in lung ex-
plants cultured for 3 d in the presence of a mAb to LM b1/g1
chains, a monoclonal antibody to LM-a2 chain, or normal mouse
IgG (b).The Journal of Cell Biology, Volume 139, 1997 560
The simplest mechanism of cell–cell interaction leading
to LM a1 chain synthesis is that a molecule, or molecules,
produced by one cell type induces the synthesis of LM a1
by the other. For example, PDGF-A is produced by lung
epithelial cells and exerts its effect on the mesenchymal
cells surrounding them (Boström et al., 1996). Similarly,
scatter factor is produced by mesenchymal cells but acts
on epithelial cells (for review see Rosen et al., 1994). Al-
ternatively, cell–cell interaction could involve a regulatory
factor with autocrine and paracrine control over LM a1
expression. In such a case, LM a1 chain could be induced
in both cell types. Obviously, mediator roles could be played
by extracellular matrix components and/or their receptors,
instead of cytokines.
Unfortunately, very little is known about the mecha-
nisms regulating LM expression. Retinoic acid has been
shown to stimulate LM-1 synthesis by embryonic cells
(Carlin et al., 1983) and has been implicated as the media-
tor of epithelial–mesenchymal interactions in the tooth
(Mitsiadis et al., 1995). However, although retinoic acid
seems to play a role in lung morphogenesis (Schuger et al.,
1993), it should be stressed that it does not affect LM-1
synthesis in lung organ cultures, monocultures, or cocul-
tures (Mitra, R., and L. Schuger, unpublished observations).
LM a1 Chain Is Synthesized by Epithelial and 
Mesenchymal Cells
There has been some uncertainty in the literature as to
what cells synthesize LM a1 chain. Using in situ hybridiza-
tion, Ekblom et al. (1990) described LM a1 chain mRNA
in epithelial cells only; however, we detected LM a1 chain
mRNA in both the epithelium and the mesenchyme
(Schuger et al., 1992). More recently, LM a1 chain mRNA
has been reported in the epithelium and in mesenchymal
cells close to it (Thomas and Dziadek, 1994). In the cur-
rent study, we could not determine by immunobloting or
immunoprecipitation which cell type synthesizes the LM
a1 chain. Furthermore, since its immunodetection was re-
stricted to the epithelial–mesenchymal interface, immuno-
histochemistry was not contributory. The origin of LM a1
chain was however elucidated by exposing cocultures to
brefeldin A, a fungal metabolite that blocks protein secre-
tion (Klausner et al., 1992). These studies showed that in
epithelial–mesenchymal cocultures exposed to brefeldin
A, LM a1 chain accumulated in both the epithelial and
mesenchymal cells, confirming its origin in both cell types.
Ekblom and coworkers observed that the development
of epithelial cell polarity coincides with the expression of
LM a1 chain in the developing kidney (Klein et al., 1988;
Ekblom et al., 1990). Based on experimental studies, the
authors proposed that one of the functions of LM a1 chain
is to induce epithelial cell polarization (Klein et al., 1988).
Our studies did not test the role of LM a1 chain in epithe-
lial cell polarization but suggested that polarized cells pro-
duce more LM a1 chain than their unpolarized counter-
parts. For example, cocultures established in Millipore
inserts, which allow epithelial cells to form spheroids and
cysts surrounded by concentric layers of mesenchymal
cells, synthesized higher levels of LM a1 chain than sur-
face-anchored bilayer cocultures (as shown in Fig. 3).
Our studies as well as others (Virtanen et al., 1996) con-
firmed that the developing lung produces LM a2 chain.
Immunoprecipitation studies indicated that LM a2 chain
is secreted by the cells as part of LM-2 (a2, b1, g1; He, L.,
and L. Schuger, unpublished results). In contrast to LM a1
chain, LM a2 chain is not regulated by epithelial–mesen-
chymal contact and may serve different functions than
LM-1. So far, the LM a2 chain has been shown to be es-
sential for myotube stability (Vachon, 1996) in skeletal
muscle, however its role in smooth muscle biology remains
to be elucidated. Noteworthy, LM-2 deficiency is the un-
derlying defect in several muscular dystrophies in which
respiratory problems lead to early death (Mendell et al.,
1995). However, at the present time, it is unclear whether
these are primary to the lung or secondary to poor ventila-
tion due to muscular dysfunction.
LM a1 Chain May Be Involved in Bronchial Smooth 
Muscle Development
Lung explants cultured in the presence of antibodies
against LM a1 chain exhibited alterations in peribronchial
mesenchymal cell shape and synthesized lower levels of
smooth muscle a actin and desmin. The anti-LM a1 chain
antibody used in these studies reacts with the COOH-ter-
minal G domain of the LM a1 chain, a major adhesion site
for several cell types, including myofibroblasts (Engvall,
1994). Therefore, it is likely that the antibody perturbed
mesenchymal cell adhesion to LM-1 and this in turn re-
sulted in abnormal smooth muscle cell phenotype.
Interestingly, two previous studies reported the differ-
entiation of mesenchymal cells into smooth muscle upon
prolonged contact with the epithelium (Cunha et al., 1992;
Duluc et al., 1994). However neither study explored possi-
ble mechanisms underlying this process. In light of our re-
sults, it may be possible that LM a1 chain was induced by
the epithelial–mesenchymal contact, facilitating the differ-
entiation of mesenchymal cells into smooth muscle.
Most mesenchymal cells in the developing lung have a
round configuration and obviously do not express smooth
muscle markers. Interestingly, stretching forces cause un-
differentiated mesenchymal cells to express smooth mus-
cle-specific proteins (Yang, Y., and L. Schuger, unpub-
lished observations). Based on this observation, we propose
that in the lung explants exposed to anti-LM a1 antibody,
the decreased peribronchial cell attachment to BM LM-1
prevented them from stretching in response to bronchial
intraluminal pressure. The deficient stretching capability
then resulted in a defective smooth muscle phenotype.
On the other hand, LM-1 has a direct effect on muscle
cell shape, unrelated to stretching (Öcalan et al., 1988),
and that per se may explain our findings. Furthermore,
LM-1 plays roles in proliferation, migration, and differen-
tiation of myoblasts (Goodman et al., 1989; von der Mark
and Öcalan, 1989; Kroll et al., 1994; Vachon et al., 1996).
Therefore, LM a1 chain may influence smooth muscle dif-
ferentiation via different mechanisms.
In summary, we have shown that while LMs a2, b1, and
g1 chains are steadily produced by embryonic lung epithe-
lial and mesenchymal cells, the synthesis of LM a1 chain is
controlled by epithelial–mesenchymal interactions. Our
studies further suggest that LM a1 chain may play a role in
the development of bronchial smooth muscle, perhaps bySchuger et al. Laminin a1 Synthesis Is Involved in Smooth Muscle Development 561
controlling peribronchial mesenchymal cell attachment,
shape, and ability to respond to stretching forces. Addi-
tional studies focused on the biological activities of LM-1
on smooth muscle cell differentiation will be required to
elucidate the mechanism whereby LM-1 affects bronchial
smooth muscle development.
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